Mackewicz C E, Garovoy M R, Levy J A
Department of Medicine, Department of Surgery, School of Medicine, University of California, San Francisco, San Francisco, California 94143-1270, USA.
J Virol. 1998 Dec;72(12):10165-70. doi: 10.1128/JVI.72.12.10165-10170.1998.
CD8(+) T cells from human immunodeficiency virus (HIV)-infected individuals can suppress HIV replication in cultured CD4(+) cells by a noncytotoxic mechanism. Efficient suppression of HIV replication (>90% reduction) does not require HLA class I or class II histocompatibility between the effector CD8(+) T cells and the infected target CD4(+) T cells. However, maximal control of HIV production occurs when the CD8(+) effector cells and CD4(+) target cells are syngeneic. In some cases, more than 20-fold fewer syngeneic CD8(+) T cells were required to achieve the same degree of HIV inhibition as HLA-mismatched CD8(+) T cells. The increased antiviral activity seen in the syngeneic setting did not map exclusively to either the HLA class I or class II locus. These findings suggest that genetic compatibility (potentially, but not necessarily, at the HLA class I and class II loci) regulates CD8(+) T-cell noncytotoxic antiviral activity against infected CD4(+) T cells.
来自人类免疫缺陷病毒(HIV)感染者的CD8(+) T细胞可通过非细胞毒性机制抑制培养的CD4(+) 细胞中的HIV复制。高效抑制HIV复制(降低>90%)并不要求效应性CD8(+) T细胞与受感染的靶CD4(+) T细胞之间具有HLA I类或II类组织相容性。然而,当CD8(+) 效应细胞和CD4(+) 靶细胞同基因时,对HIV产生的控制最为有效。在某些情况下,与HLA不匹配的CD8(+) T细胞相比,实现相同程度的HIV抑制所需的同基因CD8(+) T细胞数量要少20倍以上。在同基因环境中观察到的抗病毒活性增加并非仅定位于HLA I类或II类基因座。这些发现表明,基因相容性(可能但不一定在HLA I类和II类基因座)调节CD8(+) T细胞对受感染CD4(+) T细胞的非细胞毒性抗病毒活性。